Many healthcare founders ask this question at the wrong time — usually after a CQC inspector, investor, or regulator has already raised it for them. The answer is rarely complicated, but getting there requires an honest assessment of where your organisation sits on the clinical complexity and regulatory risk spectrum.
This article is a practical guide to understanding when your organisation needs a Medical Director, what triggers that need, and what the consequences are of leaving it too long.
The Formal vs Operational Distinction
There are two distinct reasons you might need a Medical Director. Understanding which applies — or whether both do — is the first step.
Formal / regulatory requirement: Some organisations are required by their regulator or registration conditions to have a named Medical Director or Responsible Officer. This is a compliance requirement, not a strategic choice. Failing to meet it is a registration risk.
Operational need: Many organisations do not have a formal regulatory requirement but have reached a stage where operating without senior clinical leadership creates unacceptable risk — to patients, to staff, to the organisation's reputation, and to its ability to fundraise or grow.
Organisations With a Formal Regulatory Requirement
The following types of organisations typically have a formal or regulatory requirement for a named Medical Director or clinical lead:
- CQC-registered providers: All providers registered with the Care Quality Commission must identify a nominated individual responsible for the quality and safety of the regulated activity. For many clinic types, this must be a registered medical practitioner.
- NHS-contracted providers: Organisations delivering NHS-commissioned services are typically required to demonstrate senior clinical leadership and governance structures meeting NHS contract requirements and the NHS Standard Contract.
- MHRA-licensed manufacturers: Medical device manufacturers and pharmaceutical companies require qualified persons and, in many cases, a named responsible person with clinical expertise.
- Providers of certain regulated activities: Organisations operating under professional regulatory frameworks (GPhC, NMC, HCPC) often require clinical director-level oversight for their regulated activities.
If your organisation falls into any of these categories and does not currently have a named Medical Director, this is an immediate compliance priority — not a future consideration.
The Operational Triggers: When Do You Actually Need One?
Beyond formal requirements, these are the clearest signals that your organisation needs senior clinical leadership now:
1. You are preparing to approach NHS buyers or commissioners
NHS procurement processes — a contract tender, a digital health assessment (DTAC), or a clinical safety review under DCB0129 — will ask who is clinically responsible for your product or service. A CEO or Operations Director cannot answer that question credibly. If you are in active NHS sales conversations, you need a named clinical lead before the first substantive meeting.
2. You are preparing for a fundraising round
Investors conducting due diligence on a health technology or healthcare company will scrutinise clinical governance, regulatory status, and clinical risk. A company with no senior clinical leadership is a materially higher-risk investment. Many Series A and Series B rounds in health tech are delayed or devalued because clinical governance was flagged in due diligence. Appointing a fractional CMO ahead of a raise addresses this directly and credibly.
3. You have received — or are expecting — a CQC inspection
CQC inspections in any sector (primary care, independent hospitals, care homes, cosmetic surgery) will assess whether your organisation has appropriate clinical leadership, governance, and accountability. Preparing for an inspection without a Medical Director is preparing to fail it. CQC inspectors are experienced at identifying whether governance frameworks are genuinely embedded or have been assembled in a hurry for the inspection.
4. You have experienced a serious patient safety incident
A serious incident — a patient harm event, a never event, a complaint escalating to the regulator — is a clear signal that clinical governance is insufficient. Responding to a serious incident without senior clinical leadership is not just a governance failure; it can expose the organisation and its directors to personal liability and is likely to attract regulatory scrutiny of your wider governance arrangements.
5. Your clinical staff have no senior clinician to escalate concerns to
If you have nurses, paramedics, pharmacists, or junior doctors working in your organisation and no senior clinician for them to escalate clinical concerns to, you have a live patient safety risk that professional indemnity providers will regard as unacceptable. This is one of the most frequently overlooked triggers for appointing a Medical Director, and one of the most straightforward to resolve with a fractional appointment.
6. You are making clinical claims in regulated marketing or product materials
MHRA guidance, ASA regulations, and the MHRA's Blue Guide all require that clinical claims are overseen by a responsible medical practitioner. Consumer health brands, supplement companies, digital health apps, and MedTech companies that make health claims without a named medical lead are operating a regulatory and reputational risk that can materialise quickly.
7. You are applying for grants, tenders, or regulated contracts
NIHR grant applications, Innovate UK funding, NHS procurement frameworks, and regulated tender processes all routinely ask for evidence of clinical leadership, governance structures, and named clinical responsible persons. Absent this, applications are typically rejected at the sifting stage.
The Cost of Waiting
There is a common and unfortunate pattern in organisations that engage fractional CMO services: they waited longer than they should have. The cost of waiting typically takes one of four forms:
- A CQC inspection resulting in 'Requires Improvement' or 'Inadequate' ratings — which then require intensive remediation, often with a fractional CMO brought in at crisis pace and significantly higher cost
- A fundraising round delayed or repriced because clinical governance was flagged in due diligence — a factor that investors routinely cite in health tech deals
- An NHS procurement opportunity lost because there was no credible clinical lead to name in the tender submission
- A regulatory submission delayed because there was no one with the necessary clinical expertise and regulatory authority to own it
In every one of these cases, the cost of the event significantly exceeded the cost of a fractional CMO engagement that could have prevented it. The question is not whether you can afford a Medical Director. It is whether you can afford not to have one.
The Fractional Model as the First Appointment
For most growing organisations, the fractional model is the right first appointment. It provides genuine board-level clinical leadership at a cost and time commitment that is proportionate to the organisation's stage — without the overhead of a full-time hire or the disruption of a temporary interim placement.
A fractional CMO can be in place within two to three weeks of a first conversation. A full-time CMO hire takes three to six months and costs a minimum of £30,000–£60,000 in recruiter fees before the successful candidate starts. For most organisations, the answer to "when do we need a Medical Director?" is "sooner than you think, and the fractional model is the right way to do it."
A Simple Self-Assessment
Ask yourself these questions honestly. If you answer yes to two or more, you need a Medical Director now:
- Does your organisation provide or enable clinical services to patients or service users?
- Are you registered with, or subject to inspection by, the CQC, MHRA, NHS England, or any other healthcare regulator?
- Do you have clinical staff (nurses, paramedics, doctors, pharmacists) working within your organisation with no named senior clinician to escalate to?
- Are you preparing for a fundraising round, NHS procurement bid, or regulated tender in the next six months?
- Does your product or marketing make health claims that require clinical oversight?
- Has a regulator, investor, or NHS buyer raised the question of your clinical governance in the last twelve months?
Not sure whether your organisation needs a Medical Director? Book a 15-minute confidential discovery call to talk it through — no obligation, and we'll be honest about what you need.
Book a Free 15-Minute Discovery Call →